Brickell Biotech, Inc. Gains 22.48%
Fri, Feb 04, 2022 at 05:30 PM
Brickell Biotech, Inc. (BBI:NASDAQ) jumped higher at $0.28, a gain of 22.5%. The stock got featured on our News Catalysts scanner on Wed, Feb 02, 2022 at 07:59 AM in the 'BIOTECH' category. From Fri, Jan 21, 2022, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Tue, Jan 18, 2022 at $0.4 with a volume of 228M+.
About Brickell Biotech, Inc. (BBI:NASDAQ)
Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.
Top 10 Gainers:
- Snap Inc. (SNAP:NYSE), 58.82%
- Bill.com Holdings, Inc. (BILL:NYSE), 36.05%
- Sphere 3D Corp. (ANY:NASDAQ), 31.17%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 30.23%
- eGain Corporation (EGAN:NASDAQ), 26.82%
- IRadimed Corporation (IRMD:NASDAQ), 23.66%
- Brickell Biotech, Inc. (BBI:NASDAQ), 22.48%
- Aurora Innovation Inc. (AUR:NASDAQ), 22.15%
- Nuverra Environmental Solutions, Inc. (NES:NYSEMKT), 22.11%
- Redbox Entertainment Inc. (RDBX:NASDAQ), 20.2%